Navigation Links
First Plant Genomics Yield Technology Progresses
Date:7/23/2012

HAYWARD, Calif., July 23, 2012 /PRNewswire/ -- Mendel announced today that its flagship yield technology has taken another important step towards the market. This technology will be employed by Monsanto in its new soybean yield trait. Last week, as part of its assessment process, the USDA's Animal and Plant Health Inspection Service (APHIS) made available for public comment a petition requesting deregulation of the high-yield soybean trait. Higher-yielding soybeans are aimed at boosting the intrinsic yield potential of the soybean. In addition to developing the underlying technology for the yield trait, Mendel has done critical research to determine the molecular basis for the yield improvement and to support the regulatory approval process. The technology is currently in Phase 3 of Monsanto's product pipeline. 

Mendel and Monsanto have worked together on the development of biotechnology traits for more than a decade in many crops, including corn, soy, cotton and canola. This exclusive collaboration ended in 2011, enabling Mendel to develop and maintain ownership of its new technologies while working with a broader array of commercial partners from the beginning of 2012.

Mendel's work in this field has enabled it to develop a unique understanding of plant gene regulatory networks (PGRNs) and this is the basis for Mendel's ongoing discovery and application work across a variety of fields. Mendel is now using its PGRN platform to crack the code of crop performance in the field. While much private and public investment has been made into determining the physical structure of crop genomes, the Mendel PGRN platform instead focuses on the expression of crop genomes, which enables Mendel to translate genomic information into crop productivity traits.

Mendel is now investing substantially to identify new PGRNs for improved yield and resource use efficiency. Mendel has already identified a number of promising and novel PGRNs based on these screens, and is developing a robust patent estate to protect these new inventions. 

This new investment has been funded by an inside financing round completed in late 2011, with participation from all of Mendel's later-stage investors. Key to this investment is Mendel's shift from an exclusive partnering model to an "open architecture" model in which Mendel will license, co-develop and commercialize products with a broad range of customers across the agricultural industry. 

About Mendel.
Mendel is the leading plant science company meeting the needs of global agriculture. For over fifteen years, Mendel has been deploying its PGRN platform and proprietary tools to harness a crop's genetic potential, in order to enhance agricultural productivity, resource use efficiency and crop quality. This PGRN platform has identified technologies for next-generation yield traits in Monsanto's product pipeline. PGRNs are also the foundation of a collaboration with Bayer CropScience to develop a pioneering class of crop performance chemistries. Crop protection is a third major market segment for Mendel, with a focus on developing new herbicide targets and herbicide product candidates using this same platform. Mendel is actively seeking collaborators to develop novel products and technologies across a broad array of agricultural applications.

For more information, visit: www.mendelbio.com.

Contact Greg Ikonen, Sr. VP Corporate Development, 510-259-6007.


'/>"/>
SOURCE Mendel Biotechnology, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. First Gene Therapy in Western World Receives Positive Opinion in Europe from CHMP
2. First detailed timeline established for brains descent into Alzheimers
3. Ethical Corporation Names Life Technologies First CSO Sustainability Executive of the Year
4. Janssen Research & Development, LLC, Sponsors First of its Kind Research Initiative to Advance Multiple Sclerosis Science
5. infirst HEALTHCARE Established to Launch Novel Consumer Medicines
6. Hark! Group demonstrates first heralded single photon source made from silicon
7. First 3-D nanoscale optical cavities from metamaterials
8. First Genetic Cure For Cancer Anchors Provocative New Thriller
9. Prosperous Agriculture Reports Outstanding Sales Result for First Half of 2012
10. Nourish the World! Terra Biotech Receives Thanks and Praise After First Shipment of 10,000 Servings of Nectr Core Vitamin Powder to Orphans in Ghana, Africa
11. Beyond Batten Disease Foundation and American Brain Foundation Launch First Clinical Research Fellowship to Treat and Cure Juvenile Batten Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the ... the Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s ... how hardware projects are designed, built and brought to market. , The Design ...
(Date:6/23/2016)... ... , ... In a new case report published today in STEM CELLS Translational ... lymphedema after being treated for breast cancer benefitted from an injection of stem cells ... this debilitating, frequent side effect of cancer treatment. , Lymphedema refers to ...
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
(Date:6/23/2016)... 23, 2016 On Wednesday, June 22, ... down 0.22%; the Dow Jones Industrial Average edged 0.27% lower ... 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the following ... Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing ...
Breaking Biology Technology:
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
(Date:5/3/2016)... 2016  Neurotechnology, a provider of high-precision biometric ... Biometric Identification System (ABIS) , a complete system ... ABIS can process multiple complex biometric transactions with ... fingerprint, face or iris biometrics. It leverages the ... MegaMatcher Accelerator , which have been used ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
Breaking Biology News(10 mins):